Sativus Tech Corp.
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsSativus Tech Corp. is a Delaware holding company that, through its 54%-owned Israeli subsidiary Saffron-Tech Ltd., is developing technology for growing saffron in controlled indoor environments and has ceased its earlier home plant-growing device business.
What they do
Sativus Tech Corp., formerly SEEDO CORP., was formed in Delaware on January 16, 2015. It previously sold a plant growing device managed by an AI algorithm, but ceased those operations in 2020 due to financial and operational difficulties. It now operates through Saffron-Tech Ltd., a 54%-owned Israeli subsidiary formed July 19, 2020, which is developing a fully automated, remotely managed system to grow saffron and other vegetables and exotic plants and mushrooms. The company reports it is in advanced stages of developing and testing the system and describes the technology as turnkey automated growing containers for year-round saffron.
Revenue drivers
- Saffron cultivation technology (Saffron-Tech Ltd.) — The company describes its focus as development of agriculture and technology products for exotic plants and mushrooms, including a turnkey automated container growing system for high-quality, high-yield saffron. No segment-level revenue is disclosed for this activity in the provided excerpts and no revenue is discussed for fiscal 2024 or 2025.
- Legacy home plant-growing device business (ended) — Prior to July 2020 the company sold a plant growing device controlled by an AI algorithm for consumers to grow herbs and vegetables; the company states it ceased these operations during 2020 due to financial and operational difficulties.
Recent performance
Net losses have widened each year: ($324,000) in 2023, ($680,000) in 2024, and ($869,000) in 2025, after ($3.9M) in 2021 and ($1.5M) in 2022. Diluted EPS went from ($0.08) in 2023 to ($0.24) in 2024 and ($0.32) in 2025. Operating cash flow was negative each year, including ($488,000) in 2024 and ($701,000) in 2025. At June 30, 2026, the company reported total assets of $268,000, total liabilities of $3.9M, shareholder equity of ($3.6M), and cash and equivalents of $85,000. The most recent quarterly revenue figures provided are from 2019 (e.g., $383,000 for the quarter ended 2019-06-30 and $310,000 for 2019-09-30), and no later quarterly revenue is shown.
Strategy
Management states the company, through Saffron Tech, is focusing on in-house research and development of agriculture technology products, including exotic plants and mushrooms, and that no assurance exists these can be developed, commercialized or marketed.
Risks
- Negative cash flow and liquidity — The company had $85,000 of cash and equivalents at June 30, 2026 against $3.9M of total liabilities and $3.6M of negative shareholder equity, with operating cash flow negative in each year from 2021 through 2025 (most recently ($701,000)).
- No recent revenue — The most recent revenue figures in the provided data are from 2019, and no revenue is disclosed for fiscal 2024 or 2025 alongside rising net losses.
- Controlled-environment agriculture and competition — The filings cite risks around developing and commercializing technology for controlled-environment agriculture and competition from larger competitors, while stating the business has limited operating history.
- Smaller reporting company and emerging growth company status — The company is a smaller reporting company and emerging growth company, exempt from certain requirements such as auditor attestation of internal controls under Section 404(b) of the Sarbanes-Oxley Act and stockholder advisory votes on executive compensation.
Outlook
Management says Saffron Tech plans to roll out its proof of concept in the coming months, providing turnkey automated growing containers for high-quality, high-yield saffron all year round. It also says the company is in advanced stages of developing and testing a fully automated, remotely managed system for growing saffron anywhere and anytime. The filings note actual results could differ materially from forward-looking statements due to risks and uncertainties.